Publicacións (71) Publicacións de Isabel Martín Herranz

2024

  1. Hospital pharmacy towards 2030

    Farmacia Hospitalaria, Vol. 48, pp. S52-S58

  2. Observational Study to Compare Biological Drug Concentration Quantification Techniques and Immunogenicity in Patients with Immune-Mediated Diseases

    Biomedicines, Vol. 12, Núm. 4

2023

  1. Artículo traducido] Prevalencia de reacciones adversas a medicamentos asociadas a visitas al servicio de urgencias y factores de riesgo de hospitalización

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 1, pp. T20-T25

  2. Farmacia hospitalaria y robotización en el área de pacientes ingresados

    I+S: Revista de la Sociedad Española de Informática y Salud, Núm. 153, pp. 19-24

  3. Lipid profile changes associated with antiretroviral therapies in a real-world cohort

    Farmacia Hospitalaria, Vol. 47, Núm. 5, pp. 210-217

  4. Medication reconciliation for patients after their discharge from intensive care unit to the hospital ward

    Farmacia Hospitalaria, Vol. 47, Núm. 3, pp. T121-T126

  5. Renal profile of patients treated with elvitegravir/ cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort

    European Journal of Hospital Pharmacy, Vol. 30, Núm. 4, pp. 221-226

  6. Treatment of high-risk bleeding with susoctocog alfa in a patient with acquired haemophilia A and a nosocomial severe acute respiratory syndrome coronavirus 2 infection

    European Journal of Hospital Pharmacy, Vol. 30, Núm. 3, pp. 177-179

  7. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA)

    Epilepsy and Behavior, Vol. 145

2022

  1. Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

    Dermatology and Therapy, Vol. 12, Núm. 3, pp. 761-770

  2. Discontinuation due to neuropsychiatric adverse events with efavirenz-and dolutegravir-based antiretroviral therapy: a comparative real-life study

    European Journal of Hospital Pharmacy, Vol. 29, Núm. 4, pp. 207-211

  3. Evaluation of a Telemedicine pharmaceutical care program for coordination patient's transfer between hospital and primary care, using Telepharmacy

    Farmacia Hospitalaria, Vol. 46, pp. 15-23

  4. Incidence and risk factors for mortality in patients treated with combined ceftaroline for Gram-positive infective endocarditis

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 41, Núm. 5, pp. 827-834

  5. Intoxicación por dióxido de cloro

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 5, pp. 308-310

  6. Real-world use of ustekinumab therapeutic drug monitoring in moderate to severe psoriasis

    Frontiers in Medicine, Vol. 9

2021

  1. Continuous infusion of antibiotics using elastomeric pumps in the hospital at home setting

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 34, Núm. 3, pp. 200-206

  2. Development of the @Antidotos_bot chatbot tool for poisoning management

    Farmacia Hospitalaria, Vol. 45, Núm. 4, pp. 180-183

  3. E-Interconsultations between a hospital pharmacy service and primary care pharmacy units in Spain

    European Journal of Hospital Pharmacy, Vol. 28, Núm. 4, pp. 202-206

  4. Influence of drug-drug interactions on effectiveness and safety of direct-acting antivirals against hepatitis C virus

    European Journal of Hospital Pharmacy, Vol. 28, Núm. 1, pp. 16-21

  5. Neurotoxicity associated with acyclovir and valacyclovir: A systematic review of cases

    Journal of Clinical Pharmacy and Therapeutics, Vol. 46, Núm. 4, pp. 918-926